Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to investigate a possible correlation between the change in PCO2 during a hyperoxia-test and the change in PCO2 during walking in people with COPD
Rationale:
Carbon dioxide partial pressure (PCO2) varies significantly in patients with advanced chronic obstructive pulmonary disease (COPD). Data from the Swedish LTOT Registry showed that PCO2 is an independent predictor for mortality and that there is a U-shaped relationship. Patients with advanced COPD who are still normocapnic at rest may still develop a clinically relevant, exercise-induced carbon dioxide (CO2) retention during exercise/ activity. It is also known that altered breathing patterns at night in COPD patients can lead to nocturnal hypercapnia, especially during REM sleep. The course of PCO2 cannot be reliably predicted by lung function parameters or resting blood gas analysis. Since exercise tests with blood gas control or nightly PCO2 monitoring are rarely performed in clinical routine, exercise induced CO2 retention often remains undetected. In the literature, there is little information on PCO2 behaviour under everyday conditions (with or without LTOT) such as rest, physical exertion and nightly sleep. Therefore, predictors that could describe the PCO2 patterns are missing. However, one former study by O'Donnel from 2002 showed that the change in CO2 under hyperoxia conditions could provide predictive information for the change in CO2 with exercise.
Objective:
Primary aim of this study is to investigate whether the change of PCO2 during a hyperoxia-test (10l/min O2 at rest) correlates with the change of PCO2 during walking exercise with either a: l/min O2 as prescribed; b: medical air; c: 10l/min O2.
Design:
This study is a randomized, controlled cross-over trial. Following an initial maximal incremental shuttle walk test (ISWT), the participant will perform 3 endurance shuttle walk tests (ESWT) at 85% of the maximum ISWT pace on three consecutive days (24h break between ESWTs). In a randomized order, participants will perform one ESWTs with O2-flow as prescribed (e.g. study day 1), one with medical air (same flow rate as prescribed oxygen) (e.g. study day 2) and one with 10l/min O2 (e.g. study day 3). An additional hyperoxia test (10l/min O2 for ten minutes; at resting condition) will be perfomed on each day prior to performing an ESWT.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Randomised to begin with oxygen-supplementation at 10L/min during ESWT | Experimental | Randomised order of tests starting with the 10L/min O2, during the ESWT followed by prescribed O2 flow rate or medical air in randomised order on seperate days |
|
| Randomised to begin with medical air supplementation at prescibed O2 flow rate during ESWT | Experimental | Randomised order of tests starting with the medical air during the ESWT followed by prescribed O2 flow rate or 10L/min O2 in randomised order on seperate days |
|
| Randomised to begin with oxygen supplementation at prescibed O2 flow rate during ESWT | Experimental | Randomised order of tests starting with the prescribed O2 flow rate, during the ESWT followed by 10L/min O2 or medical air in randomised order on seperate days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxygen therapy | Other | Supplemental O2 at rest of 10 l/min for ten minutes followed by supplemental O2 at the prescribed exercise O2-flow rate during ESWT. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in PCO2 during hyperoxia at rest | pCO2 measured by capillary blood gases taken before and after the hyperoxia test | Change from baseline to after 10 minutes breathing 10L/min oxygen |
| Change in PCO2 from rest to end exercise (endurance shuttle walk test) | pCO2 measured by capillary blood gases taken before and after the ESWT | Change from baseline to the end of the ESWT, up to 20 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Transcutaneous partial pressure of CO2 (TcPCO2) during hyperoxia test | TcPCO2 measured by continuous transcutaneous recording via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland) | Continuously from baseline to 10 minutes breathing 10L/min oxygen |
| Transcutaneous partial pressure of CO2 (TcPCO2) during endurance shuttle walk test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Tessa Schneeberger | Contact | +498652931540 | +498652931540 | TSchneeberger@Schoen-Klinik.de |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Klinikum Berchtesgadener Land, Schön Kliniken | Recruiting | Schönau am Königssee | 83471 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
| ID | Term |
|---|---|
| D010100 | Oxygen |
| D000388 | Air |
| ID | Term |
|---|---|
| D018011 | Chalcogens |
| D004602 | Elements |
| D007287 | Inorganic Chemicals |
| D005740 | Gases |
| D001272 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Medical Air | Other | Supplemental O2 at rest of 10 l/min for ten minutes followed by medical Air at prescribed O2 flow rate during ESWT. |
|
| 10L/min O2 | Other | Supplemental O2 at rest of 10 l/min for ten minutes followed by 10L/min O2 during ESWT. |
|
TcPCO2 measured by continuous transcutaneous recording via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland) |
| Continuously during ESWT, up to 20 minutes |
| Breathing frequency during hyperoxia test | Breathing frequency during the hyperoxia test measured by ApneaLink Air™ (ResMed) | Continuously from baseline to 10 minutes breathing 10L/min oxygen |
| Breathing frequency during endurance shuttle walk test | Breathing frequency during the ESWT measured by ApneaLink Air™ (ResMed) | Continuously during ESWT, up to 20 minutes |
| Heart rate during endurance shuttle walk test | Heart rate measured by continuous transcutaneous recordung via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland) | Continuously during ESWT, up to 20 minutes |
| Heart rate during hyperoxia test | Heart rate measured by continuous transcutaneous recordung via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland) | Continuously from baseline to 10 minutes breathing 10L/min oxygen |
| Change of capillary partial pressure of O2 (pO2) during endurance shuttle walk test | pO2 measured by capillary blood gases taken before and after the ESWT | Change from baseline to the end of the ESWT, up to 20 minutes |
| Change of inspiratory capacity during endurance shuttle walk test | IC measured by SpiroSense (Pari) before and after the ESWT | Change from baseline to the end of the ESWT, up to 20 minutes |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Atmosphere |
| D004777 | Environment |
| D055669 | Ecological and Environmental Phenomena |
| D001686 | Biological Phenomena |
| D008685 | Meteorological Concepts |
| D004778 | Environment and Public Health |